Advances in Oto-Rhino-Laryngology最新文献_第4页

Particle Therapy: Protons and Heavy Ions. 粒子治疗:质子和重离子。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-07-30 DOI: 10.1159/000457929

Alexandra D Jensen

引用次数: 3

Posttreatment Imaging Surveillance. 治疗后影像学监测。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-07-30 DOI: 10.1159/000457941

Davide Farina, Ivan Zorza, Salvatore Golemi, Davide Lombardi, Andrea Borghesi, Roberto Maroldi, Marco Ravanelli

{"title":"Posttreatment Imaging Surveillance.","authors":"Davide Farina, Ivan Zorza, Salvatore Golemi, Davide Lombardi, Andrea Borghesi, Roberto Maroldi, Marco Ravanelli","doi":"10.1159/000457941","DOIUrl":"https://doi.org/10.1159/000457941","url":null,"abstract":"Posttreatment imaging surveillance in patients treated for anterior skull base tumors is a multifaceted issue which - as a first step - requires tailoring of the selection of imaging technique and acquisition protocol to the clinical scenario. As a general rule, acute symptoms suggesting the onset of a complication of treatment require prompt diagnosis through an easily accessible technique, such as CT; on the other hand, monitoring recurrences in asymptomatic patients is best achieved with MRI, exploiting the inherently higher contrast resolution. The interpretation of follow-up imaging studies is challenging. First of all, it is essential to be aware of specific characteristics of the natural history that may differ significantly between histologies, influencing the pattern and timing of recurrences. Additionally, resection of the lesion and reconstruction of the defect (as well as radiation treatment) produce complex anatomical changes, which may mislead inexperienced radiologists; this concept emphasizes the centrality of collecting accurate information on treatment modalities and procedures applied before scanning in each patient. This enables the pattern of expected posttreatment changes to be anticipated and, consequently, recurrences or complications to be more easily identified.","PeriodicalId":39848,"journal":{"name":"Advances in Oto-Rhino-Laryngology","volume":"84 ","pages":"218-230"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38208346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Treatment Options for Recurrent Anterior Skull Base Tumors. 复发性前颅底肿瘤的治疗选择。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-07-30 DOI: 10.1159/000457942

Ester Orlandi, Nicola Alessandro Iacovelli, Rossana Ingargiola, Carlo Resteghini, Paolo Bossi, Lisa Licitra, Marco Ferrari, Piero Nicolai

{"title":"Treatment Options for Recurrent Anterior Skull Base Tumors.","authors":"Ester Orlandi, Nicola Alessandro Iacovelli, Rossana Ingargiola, Carlo Resteghini, Paolo Bossi, Lisa Licitra, Marco Ferrari, Piero Nicolai","doi":"10.1159/000457942","DOIUrl":"https://doi.org/10.1159/000457942","url":null,"abstract":"Malignancies of the anterior skull base are rare and recur in 40-80% of treated cases, varying with substantial variance according to histology, stage at primary diagnosis, and other factors. Most recurrences manifest within 2-5 years after primary treatment, but some histologies can relapse even decades after the first presentation. Management of recurrent anterior skull base tumors is challenging and a wide variety of treatment options are available. Similar to the primary setting, surgery is the mainstay of treatment. However, only few patients are likely to be suitable for salvage surgery after restaging. In this scenario, non-surgical options such as re-irradiation with photon or heavy particles may play a role, although the potential toxicity and benefits of treatment needs to be considered on a case-by-case basis. Moreover, stereotactic technologies are emerging as an adjunct valuable tool to minimize side effects. Chemotherapy is acquiring a relevant role in the primary treatment of sinonasal malignant lesions involving the anterior skull base in the neoadjuvant setting or in combination with radiotherapy, but evidence of its efficacy in the treatment of the recurrent/metastatic disease is very limited. The specific drugs employed vary considerably and need to be paralleled with the biology of the different histologies.","PeriodicalId":39848,"journal":{"name":"Advances in Oto-Rhino-Laryngology","volume":"84 ","pages":"231-245"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38208347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Preface. 前言。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-07-30 DOI: 10.1159/000505104

Piero Nicolai, Patrick J Bradley

引用次数: 0

Injection Laryngoplasty for Management of Neurological Vocal Fold Immobility. 注射喉成形术治疗神经性声带不动。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-11-09 DOI: 10.1159/000456684

Mark S Courey, Matthew R Naunheim

{"title":"Injection Laryngoplasty for Management of Neurological Vocal Fold Immobility.","authors":"Mark S Courey, Matthew R Naunheim","doi":"10.1159/000456684","DOIUrl":"https://doi.org/10.1159/000456684","url":null,"abstract":"Injection laryngoplasty as used in this chapter is synonymous with the term \"injection augmentation.\" Injection augmentation is a technique designed to enhance glottic closure in patients with glottic insufficiency, or failure of glottic closure, by injecting material into the lateral aspect of the vocal fold to move the vibrating surface to the midline. This type of injection augments the vocal fold and improves glottic closure. Injection augmentation originated over 100 years ago. However, the current indications, techniques, and materials have changed significantly. Paralysis, defined as loss of function due to neu-rological injury, remains a common cause of glottic insufficiency. In cases of paralysis, nerve function to adduct the vocal folds for voice production and coughing is interrupted, bilaterally or unilaterally, and the glottis becomes insufficient. While unilateral vocal fold paralysis remains the most common indication for vocal fold injection augmentation, due to the development of newer injectable materials and less invasive injectable techniques, surgeons routinely perform injection augmentation for glottic insufficiency due to other causes such as vocal fold paresis, vocal fold atrophy, presbylarynx, vocal fold scar, and soft tissue loss. Additionally, there is an increasing performance of vocal fold injection in the awake patient. This allows for immediate feedback and reduced anesthetic risk. Outcomes assessment for injection augmentation remains varied by lack of consensus and large-scale studies to identify the factors most instrumental in documenting optimal results. We review the history of injection laryngoplasty, the indications for injection, choice of injectate, outcomes, complications, and future directions of injection laryngoplasty for augmentation.","PeriodicalId":39848,"journal":{"name":"Advances in Oto-Rhino-Laryngology","volume":"85 ","pages":"68-84"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38581345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Other Rare Sinonasal Malignant Tumours Involving the Anterior Skull Base. 其他罕见鼻窦恶性肿瘤累及前颅底。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-07-30 DOI: 10.1159/000457940

Rahul Naga, Prathamesh S Pai

引用次数: 2

Medialization Thyroplasty and Arytenoid Adduction for Management of Neurological Vocal Fold Immobility. 内侧化甲状腺成形术和杓状内收治疗神经性声带不动。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-11-09 DOI: 10.1159/000456686

Vyas M N Prasad, Marc Remacle

{"title":"Medialization Thyroplasty and Arytenoid Adduction for Management of Neurological Vocal Fold Immobility.","authors":"Vyas M N Prasad, Marc Remacle","doi":"10.1159/000456686","DOIUrl":"https://doi.org/10.1159/000456686","url":null,"abstract":"Vocal fold immobility can be either unilateral or bilateral and partial or complete. The aim of this chapter is to discuss the management of unilateral paresis using medialization thyroplasty with or without arytenoid adduction as a means of treating neurogenic causes as opposed to mechanical fixation. Medialization thyroplasty is an open surgical procedure that is performed under local or general anesthesia. Essentially, it aims to close the glottic gap, approximating both vocal folds together and thereby allowing for restoration of the efficiency of the larynx. The glottic gap results from atrophy of the affected vocal fold and in so doing results in glottic insufficiency which causes voice breathiness, strain, fatigue, aspiration, and swallowing difficulties that make up the bulk of symptoms associated with this condition. Unlike injection laryngoplasty, medialization thyroplasty does not increase the \"bulk\" of the atrophic vocal fold but merely brings the fold closer to its unaffected partner. Besides the obvious lateralization, there is occasionally a third dimensional component to the affected fold. The slipping and prolapse forward of the arytenoid cartilage due to atrophy of the muscles supporting it and the natural declination of the facet joint it rests on cause a vertical drop of the level of the affected vocal fold that may not be remedied with the medialization procedure, hence requiring arytenoid adduction. Although attempts to medialize the vocal fold have been described in the past with limited access, the basic premise of creating a window in the thyroid cartilage remains central. The differences between materials used, their respective strengths and weaknesses, the pitfalls and pearls in achieving a good closure and improvement in voice, swallow, and safety of the airway are all discussed accordingly.","PeriodicalId":39848,"journal":{"name":"Advances in Oto-Rhino-Laryngology","volume":"85 ","pages":"85-97"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38581344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Structure, Function and Insertion of the Human Vocal Folds. 人类声带的结构、功能和插入。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-11-09 DOI: 10.1159/000456678

Friedrich Paulsen, Bernhard Tillmann

引用次数: 0

Acoustic Assessment. 声学评估。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-11-09 DOI: 10.1159/000456683

Declan Costello

引用次数: 3

Neuromuscular Disease Affecting the Larynx. 影响喉部的神经肌肉疾病。

Advances in Oto-Rhino-Laryngology Pub Date : 2020-01-01 Epub Date: 2020-11-09 DOI: 10.1159/000456694

David Lau

引用次数: 2